REIT - Office
Compare Stocks
2 / 10Stock Comparison
CMCT vs GMRE
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
CMCT vs GMRE — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | REIT - Office | REIT - Healthcare Facilities |
| Market Cap | $3M | $94M |
| Revenue (TTM) | $114M | $148M |
| Net Income (TTM) | $-68M | $2M |
| Gross Margin | -22.4% | 68.8% |
| Operating Margin | 3.1% | 24.9% |
| Forward P/E | — | 595.7x |
| Total Debt | $510M | $654M |
| Cash & Equiv. | $15M | $7M |
CMCT vs GMRE — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Creative Media & Co… (CMCT) | 100 | 0.0 | -100.0% |
| Global Medical REIT… (GMRE) | 100 | 64.6 | -35.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CMCT vs GMRE
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CMCT is the clearest fit if your priority is defensive.
- Beta 0.89, yield 100.0%, current ratio 0.22x
- 100.0% yield, vs GMRE's 63.5%
GMRE carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 5 yrs, beta 0.53, yield 63.5%
- Rev growth -1.8%, EPS growth -94.6%, 3Y rev CAGR 6.1%
- 308.1% 10Y total return vs CMCT's -59.4%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -1.8% FFO/revenue growth vs CMCT's -6.3% | |
| Quality / Margins | 1.7% margin vs CMCT's -59.4% | |
| Stability / Safety | Beta 0.53 vs CMCT's 0.89, lower leverage | |
| Dividends | 100.0% yield, vs GMRE's 63.5% | |
| Momentum (1Y) | +10.9% vs CMCT's -99.1% | |
| Efficiency (ROA) | 0.2% ROA vs CMCT's -7.9%, ROIC 2.0% vs 0.8% |
CMCT vs GMRE — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
CMCT vs GMRE — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
GMRE leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
GMRE and CMCT operate at a comparable scale, with $148M and $114M in trailing revenue. GMRE is the more profitable business, keeping 1.7% of every revenue dollar as net income compared to CMCT's -59.4%. On growth, GMRE holds the edge at +18.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $114M | $148M |
| EBITDAEarnings before interest/tax | $23M | $95M |
| Net IncomeAfter-tax profit | -$68M | $2M |
| Free Cash FlowCash after capex | -$40M | $19M |
| Gross MarginGross profit ÷ Revenue | -22.4% | +68.8% |
| Operating MarginEBIT ÷ Revenue | +3.1% | +24.9% |
| Net MarginNet income ÷ Revenue | -59.4% | +1.7% |
| FCF MarginFCF ÷ Revenue | -35.0% | +12.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | -8.9% | +18.7% |
| EPS Growth (YoY)Latest quarter vs prior year | -2.4% | -166.2% |
Valuation Metrics
CMCT leads this category, winning 3 of 4 comparable metrics.
Valuation Metrics
On an enterprise value basis, GMRE's 8.3x EV/EBITDA is more attractive than CMCT's 14.1x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $3M | $94M |
| Enterprise ValueMkt cap + debt − cash | $497M | $741M |
| Trailing P/EPrice ÷ TTM EPS | -0.09x | 115.29x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 595.67x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 14.07x | 8.35x |
| Price / SalesMarket cap ÷ Revenue | 0.03x | 0.68x |
| Price / BookPrice ÷ Book value/share | 0.02x | 0.17x |
| Price / FCFMarket cap ÷ FCF | — | — |
Profitability & Efficiency
GMRE leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
GMRE delivers a 0.5% return on equity — every $100 of shareholder capital generates $0 in annual profit, vs $-24 for CMCT. GMRE carries lower financial leverage with a 1.18x debt-to-equity ratio, signaling a more conservative balance sheet compared to CMCT's 1.91x. On the Piotroski fundamental quality scale (0–9), GMRE scores 4/9 vs CMCT's 2/9, reflecting mixed financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -24.4% | +0.5% |
| ROA (TTM)Return on assets | -7.9% | +0.2% |
| ROICReturn on invested capital | +0.8% | +2.0% |
| ROCEReturn on capital employed | +1.1% | +5.3% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 4 |
| Debt / EquityFinancial leverage | 1.91x | 1.18x |
| Net DebtTotal debt minus cash | $494M | $647M |
| Cash & Equiv.Liquid assets | $15M | $7M |
| Total DebtShort + long-term debt | $510M | $654M |
| Interest CoverageEBIT ÷ Interest expense | 0.03x | 1.14x |
Total Returns (Dividends Reinvested)
GMRE leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in GMRE five years ago would be worth $7,850 today (with dividends reinvested), compared to $410 for CMCT. Over the past 12 months, GMRE leads with a +10.9% total return vs CMCT's -99.1%. The 3-year compound annual growth rate (CAGR) favors GMRE at 1.8% vs CMCT's -65.5% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -98.3% | +6.9% |
| 1-Year ReturnPast 12 months | -99.1% | +10.9% |
| 3-Year ReturnCumulative with dividends | -95.9% | +5.6% |
| 5-Year ReturnCumulative with dividends | -95.9% | -21.5% |
| 10-Year ReturnCumulative with dividends | -59.4% | +308.1% |
| CAGR (3Y)Annualised 3-year return | -65.5% | +1.8% |
Risk & Volatility
GMRE leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
GMRE is the less volatile stock with a 0.53 beta — it tends to amplify market swings less than CMCT's 0.89 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. GMRE currently trades 89.5% from its 52-week high vs CMCT's 0.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.89x | 0.53x |
| 52-Week HighHighest price in past year | $1441.00 | $39.93 |
| 52-Week LowLowest price in past year | $3.60 | $29.05 |
| % of 52W HighCurrent price vs 52-week peak | +0.4% | +89.5% |
| RSI (14)Momentum oscillator 0–100 | 23.8 | 52.7 |
| Avg Volume (50D)Average daily shares traded | 3.9M | 147K |
Analyst Outlook
Evenly matched — CMCT and GMRE each lead in 1 of 2 comparable metrics.
Analyst Outlook
For income investors, CMCT offers the higher dividend yield at 100.00% vs GMRE's 63.51%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $40.00 |
| # AnalystsCovering analysts | — | 22 |
| Dividend YieldAnnual dividend ÷ price | +100.0% | +63.5% |
| Dividend StreakConsecutive years of raises | 0 | 5 |
| Dividend / ShareAnnual DPS | $23.89 | $22.70 |
| Buyback YieldShare repurchases ÷ mkt cap | +5.6% | 0.0% |
GMRE leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CMCT leads in 1 (Valuation Metrics). 1 tied.
CMCT vs GMRE: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is CMCT or GMRE a better buy right now?
For growth investors, Global Medical REIT Inc.
(GMRE) is the stronger pick with -1. 8% revenue growth year-over-year, versus -6. 3% for Creative Media & Community Trust Corporation (CMCT). Global Medical REIT Inc. (GMRE) offers the better valuation at 115. 3x trailing P/E (595. 7x forward), making it the more compelling value choice. Analysts rate Global Medical REIT Inc. (GMRE) a "Buy" — based on 22 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — CMCT or GMRE?
Over the past 5 years, Global Medical REIT Inc.
(GMRE) delivered a total return of -21. 5%, compared to -95. 9% for Creative Media & Community Trust Corporation (CMCT). Over 10 years, the gap is even starker: GMRE returned +308. 1% versus CMCT's -59. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — CMCT or GMRE?
By beta (market sensitivity over 5 years), Global Medical REIT Inc.
(GMRE) is the lower-risk stock at 0. 53β versus Creative Media & Community Trust Corporation's 0. 89β — meaning CMCT is approximately 69% more volatile than GMRE relative to the S&P 500. On balance sheet safety, Global Medical REIT Inc. (GMRE) carries a lower debt/equity ratio of 118% versus 191% for Creative Media & Community Trust Corporation — giving it more financial flexibility in a downturn.
04Which is growing faster — CMCT or GMRE?
By revenue growth (latest reported year), Global Medical REIT Inc.
(GMRE) is pulling ahead at -1. 8% versus -6. 3% for Creative Media & Community Trust Corporation (CMCT). On earnings-per-share growth, the picture is similar: Creative Media & Community Trust Corporation grew EPS 98. 4% year-over-year, compared to -94. 6% for Global Medical REIT Inc.. Over a 3-year CAGR, GMRE leads at 6. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — CMCT or GMRE?
Global Medical REIT Inc.
(GMRE) is the more profitable company, earning 4. 8% net margin versus -33. 4% for Creative Media & Community Trust Corporation — meaning it keeps 4. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GMRE leads at 23. 6% versus 7. 1% for CMCT. At the gross margin level — before operating expenses — GMRE leads at 78. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — CMCT or GMRE?
All stocks in this comparison pay dividends.
Creative Media & Community Trust Corporation (CMCT) offers the highest yield at 100. 0%, versus 63. 5% for Global Medical REIT Inc. (GMRE).
07Is CMCT or GMRE better for a retirement portfolio?
For long-horizon retirement investors, Global Medical REIT Inc.
(GMRE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 53), 63. 5% yield, +308. 1% 10Y return). Both have compounded well over 10 years (GMRE: +308. 1%, CMCT: -59. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between CMCT and GMRE?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.